Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Exelixis Inc (EXEL)

Exelixis Inc (EXEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Exelixis (EXEL) Q1 2024 Earnings Call Transcript

EXEL earnings call for the period ending March 31, 2024.

EXEL : 21.90 (-0.99%)
Exelixis: Q1 Earnings Snapshot

Exelixis: Q1 Earnings Snapshot

EXEL : 21.90 (-0.99%)
4 Magnificent Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

Phenomenal deals can still be found, even with the Nasdaq Composite climbing to a new all-time high.

COMP : 3.37 (+6.31%)
$NASX : 16,156.33 (+1.99%)
META : 451.96 (+2.33%)
EXEL : 21.90 (-0.99%)
S : 21.25 (-1.16%)
PINS : 40.41 (-0.22%)
2 Biotech Stocks to Buy Hand Over Fist in March

These stocks are worth buying in most months of the year.

REGN : 957.00 (+2.07%)
EXEL : 21.90 (-0.99%)
4 Thrilling Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

The growth-driven Nasdaq Composite has entered a new bull market, but plain-as-day deals can still be found.

COMP : 3.37 (+6.31%)
$NASX : 16,156.33 (+1.99%)
MA : 443.58 (+0.56%)
PUBM : 23.43 (+1.38%)
EXEL : 21.90 (-0.99%)
AMZN : 186.21 (+0.81%)
2 Stocks Under $30 to Buy and Hold

You don't need to be a millionaire to get started. Investing on a budget can work, too.

ADYEY : 12.4300 (+2.64%)
EXEL : 21.90 (-0.99%)
Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:EXEL),(NYSE:PFE),(NASDAQ:BTAI),(NYSE:BMY) EQNX::TICKER_END

ONCY : 1.1700 (unch)
ONC.TO : 1.60 (+0.63%)
EXEL : 21.90 (-0.99%)
PFE : 27.81 (+0.40%)
BTAI : 2.57 (+0.39%)
BMY : 43.99 (+0.66%)
Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies

ONCY : 1.1700 (unch)
ONC.TO : 1.60 (+0.63%)
EXEL : 21.90 (-0.99%)
PFE : 27.81 (+0.40%)
BTAI : 2.57 (+0.39%)
BMY : 43.99 (+0.66%)
4 Appealing Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip

The growth-driven Nasdaq Composite hasn't put the 2022 bear market entirely in the rearview mirror, which means opportunistic investors can still find bargains.

COMP : 3.37 (+6.31%)
$NASX : 16,156.33 (+1.99%)
NIO : 5.57 (-0.36%)
LOVE : 23.38 (+4.89%)
EXEL : 21.90 (-0.99%)
GOOGL : 167.24 (+0.37%)
GOOG : 168.99 (+0.31%)
Exelixis (EXEL) Q4 2023 Earnings Call Transcript

EXEL earnings call for the period ending December 31, 2023.

EXEL : 21.90 (-0.99%)

Barchart Exclusives

How to Invest in Quality Stocks Right Now
These 3 ETFs are worth considering for investors who are looking to add quality stocks to their portfolios, without spending the time and research on stock picking. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar